GENERAL CATALOGUE
CDK9-IN-19
HY-150562 · 50 mg
MedChemExpress · Cat: HY-150562
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/cdk9-in-19.html
Sponsored
Catalog No: HY-150562
CAS No: 2479306-60-8
Category: Cell Cycle DNA Damage
Pack Size: 50 mg
Brand: MedChemExpress
Description
CDK9-IN-19 is a highly potent and selective CDK9 inhibitor with an IC50 value of 2.0 nM. CDK9-IN-19 has excellent cellular antiproliferative activity, moderate pharmacokinetic property and low hERG inhibition. CDK9-IN-19 significantly induces tumour growth inhibition in an MV4-11 xenograft mice model. CDK9-IN-19 can be used for researching acute myeloid leukaemia AML .
More from MedChemExpress
TP-061
HY-103041
Cell Cycle DNA Damage
Guttiferone G
HY-N9892
Cell Cycle DNA Damage
Cdk14 Mouse Pre-designed siRNA Set A
HY-RS02363
Cell Cycle DNA Damage
HSP70/SIRT2-IN-2
HY-149638
Cell Cycle DNA Damage
Tucidinostat (Standard)
HY-109015R
Cell Cycle DNA Damage
CDK2 Human Pre-designed siRNA Set A
HY-RS02374
Cell Cycle DNA Damage
Palmitic acid-d2-1
HY-N0830S11
Cell Cycle DNA Damage
Cdc7-IN-1
HY-101523
Cell Cycle DNA Damage